Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||FF2589 / 1||LA / IM|
Administered by: Public Purchased by: ??
Symptoms: Dizziness, Throat irritation, Throat tightness, Pharyngeal erythema
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Preexisting Conditions: Asthma
Diagnostic Lab Data:
CDC 'Split Type':
Write-up: Patient complained of dizziness, itching of throat during observation. Vital signs initiated, patient throat assessed, redness of throat observed. Patient reported slight tightness only when swallowing, no shortness of breath. Patient remained AOX3, denied any SOB, vital signs remained stable, head clinician present during Intramuscular (right Deltoid) administration and confirmed dose. Benadryl administered to patient at 12:48 pm. Observation was extended for additional 50 minutes, Vital signs assessed through out stay. Patient reported dizziness has subsided, patient reported itching of throat has subsided 4 minutes after IM Benadryl was administered. Vital signs WNL. Patient was able to stand up, ambulate on her own. Patient reported symptoms has resolved. Patient left facility at 1:43 pm, in no distress.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166